by Sayer Ji
Amazingly, something as simple as crude honey has been found to alleviate an embarrassing scalp condition that most body care products and drugs can’t even make a dent in.
[Sponsor link: colloidal silver]
Honey’s strange power to resolve chronic dandruff and seborrheic dermatitis, while common knowledge within traditional ‘folk medicine’ systems of healing and countless personal anecdotes, has only recently been ‘clinically confirmed’ to the point where a peer-reviewed study was published on the phenomenon in the European Journal of Medical Journal, over a decade ago.
Titled, “Therapeutic and prophylactic effects of crude honey on chronic seborrheic dermatitis and dandruff,”[i] researchers investigated the use of crude honey applied topically to thirty patients with chronic seborrheic dermatitis of the scalp, face and front of the chest. Seborrheic dermatitis is a common skin disorder that mainly affects the scalp, usually causing itchy, scaly, red skin and stubborn dandruff, and is often resistant to conventional, chemical-based treatment and a significant source of embarrassment.
In the study, twenty male patients and 10 females, between the ages of 15 and 60 years, presented with scaling, itching and hair loss with lesions described as “scaling macules, papules and dry white plaques with crust and fissures.” The patients were instructed to apply diluted crude honey (90% honey diluted in warm water) every other day on the lesions with gentle rubbing for 2-3 minutes. After 3 hours, the honey was gently rinsed with warm water. The patients were monitored for changes in itching, scaling, hair loss and lesions during the treatment period, which lasted 4 weeks. The results of the study were remarkable:
“Itching was relieved and scaling was disappeared within one week. Skin lesions were healed and disappeared completely within 2 weeks. In addition, patients showed subjective improvement in hair loss.”
Additionally, those patients who saw improvement in the initial phase of treatment were enrolled in a ‘prophylactic phase,’ intended to prevent relapse, lasting six months. The results were reported as followed: